Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sawaki A et al. – One patient showed PR, and seven patients showed SD more than 24 weeks. Motesanib was found to be safe and well tolerated. The observed toxicities were consistent with Phase I study findings.

Related Articles

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09    Relevance Score: 82%

Collision tumor of the stomach: Gastric adenocarcinoma intermixed with gastrointestinal stromal tumor
Pathology International, 10/20/09    Relevance Score: 82%

Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: Report of a case
Surgery Today, 11/11/09    Relevance Score: 81%

Carney Triad in an Adult with Aggressive Behavior: The First Case in Korea
Yonsei Medical Journal, 10/30/09    Relevance Score: 80%

Molecular pathology of sarcomas: concepts and clinical implications
Virchows Archiv, 10/02/09    Relevance Score: 79%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address